CLINICAL_TRIALS
research
· 2025-06-03
Clinical Trial Update: Non-invasive Intermittent Theta Burst Stimulation of the Dorsolateral Prefrontal Cortex in Functional Movement Disorders [Phase 2]
Summary
Phase 2 clinical trial investigating non-invasive intermittent theta burst stimulation of the dorsolateral prefrontal cortex for functional movement disorder; t…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Functional Movement Disorder | Phase 2 | Status: ACTIVE_NOT_RECRUITING